No Data
No Data
Sanofi: Information Concerning the Total Number of Voting Rights and Shares - July 2024
FDA Approves ARS Pharma's Once Rejected Neffy Nasal Spray Alternative To EpiPen For Emergency Allergy Treatment
Earnings Call: Novavax Q2 2024 Results Show Promise With Sanofi Deal
IDT Australia Receives New Contract From Sanofi Australia; Shares Up 9%
COVID-19 Vaccine Maker Novavax Trims Annual Outlook As Q2 Sales Take A Hit
Sanofi's Approved Blood Cancer Drug Sarclisa Shows Improved Progression-Free Survival In Patients Eligible For Transplant
Stock Winner : Thks for ur sharing